Germany· DE-A57-740c9d96bbf440b8

Taloxa Saft

A felbamate product containing felbamate, registered in Germany by Organonhealthcare Gmbh. The same ATC class is registered in 9 of our 19 countries.

ATC N03AX10

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedTaloxa SaftATCN03AX10REGISTER NO.DE-A57-740c9d96bbf440…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Felbamate is registered in 9 of 19 countries.

Countries holding a registration under ATC N03AX10 (felbamate), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 6 of them publish a price we can compare per daily dose

Felbamate · ATC N03AX10

9 / 19 countries

  • Belgiumprice
  • Franceprice
  • Germany
  • Italyprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of felbamate costs, country by country.

Normalised to the WHO defined daily dose (2.4 g), the median price runs from $4.40 in United States to $10.58 in Switzerland — a ×2.4 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Felbamate · price per daily dose (2.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$10.58
  • IT Italy$9.01
  • US United States$4.40 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Felbamate
Manufacturer
Organonhealthcare Gmbh
Country
Germany (DE)
ATC code
N03AX10
ATC class
Felbamate
Defined daily dose
2.4 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

267 interactions on record for felbamate.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Felbamate · interactions on record

267 records

  • 12 severe
  • 221 moderate
  • 7 minor

Most severe, free to view

  • Levonorgestrel and ethinylestradiolG03AA07severe
  • Desogestrel and ethinylestradiolG03AA09severe
  • Drospirenone and ethinylestradiolG03AA12severe
  • EthinylestradiolG03CA01severe

27 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Felbamate in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All felbamate products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Taloxa
  • Belgium · Taloxa-Susp, Taloxa-Tabs
  • France · Taloxa
  • Hungary · Taloxa
  • Italy · Taloxa
  • Luxembourg · Taloxa-Susp, Taloxa-Tabs
  • Netherlands · Taloxa-Susp, Taloxa-Tabs
  • Norway · Taloxa
  • Portugal · Taloxa
  • Sweden · Taloxa

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ba5dfc98-f986-4055-8c54-3687fefb898a
GET /v1/drugs/ba5dfc98-f986-4055-8c54-3687fefb898a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Felbamate",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about felbamate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.